Emanuele Ostuni

Emanuele Ostuni is an accomplished professional in the biotechnology and pharmaceutical sectors, currently serving as CEO of ARTBIO since February 2022 and as a Scientific Advisory Board Member at Elicio Therapeutics since December 2022. Previously, Emanuele held multiple leadership roles, including Member of The Scientific Advisory Board at Anixa Biosciences, Inc., and Head of Europe for Cell and Gene Therapy at Novartis Oncology. Prior positions also include significant roles at Sandoz, where Emanuele served as Head of Business Unit Rx and Regional Alliance Manager, as well as in various capacities at Enumeral Biomedical Holdings, Inc., Nano Terra, McKinsey & Company, and Surface Logix. Emanuele began a distinguished academic career at Harvard University, where a Ph.D. in Chemistry was obtained, following a BS/MS in Chemistry from Georgetown University.